Zhijian Duan
- Transplantation top 5%
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 4
- NF-κB Signaling Pathways 4
- Immunology top 10%
- interferon and immune responses 5
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research 4
- Hepatology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Bacteriophages and microbial interactions 4
-
- SARS-CoV-2 and COVID-19 Research 3
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Zhijian Duan
38 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 86
- Transplantation 72
- Cancer Research 312
- Immunology 348
- Molecular Biology 791
- Hepatology 89
Countries citing papers authored by Zhijian Duan
This map shows the geographic impact of Zhijian Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhijian Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhijian Duan more than expected).
Fields of papers citing papers by Zhijian Duan
This network shows the impact of papers produced by Zhijian Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhijian Duan. The network helps show where Zhijian Duan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhijian Duan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 36 | |
| 8 | 2022 | 27 | |
| 9 | 2019 | 14 | |
| 10 | 2018 | 52 | |
| 11 | 2017 | 53 | |
| 12 | 2017 | 25 | |
| 13 | 2016 | 23 | |
| 14 | 2016 | 156 | |
| 15 | 2016 | 73 | |
| 16 | 2015 | 14 | |
| 17 | 2014 | 143 | |
| 18 | 2012 | 40 | |
| 19 | 2009 | 168 | |
| 20 | 2008 | 54 |
About Zhijian Duan
Zhijian Duan is a scholar working on Cancer Research, Immunology and Hepatology, having authored 39 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), interferon and immune responses (5 papers), MicroRNA in disease regulation (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Bacteriophages and microbial interactions (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), NF-κB Signaling Pathways (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Transplantation (72 citations), Cancer Research (312 citations) and Immunology (348 citations). Zhijian Duan has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Sidong Xiong, Bo Gao, June X. Zou, Wei Xu, Junjian Wang, Hong-Wu Chen, Ai‐Ming Yu, Jianzhen Xu, Wei Xu and Allen C. Gao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.